Skip to main content
DNA Labs India

OncoPro NCCN Lung Cancer Panel with PD-L1 Test

DNA Labs India | ISO 9001:2015 Certified

OncoPro NCCN Lung Cancer Panel with PD-L1 Test

Short Name: OncoPro Lung Cancer Panel

Also known as: NCCN Lung Cancer Panel, PD-L1 Liquid Biopsy Test, OncoPro Lung Genetic Test

OncoPro NCCN Lung Cancer Panel with PD-L1 Test test available at DNA Labs India for ₹140,400. Uses Next Generation Sequencing, DNA Extraction, Cell Staining on Whole blood (Liquid Biopsy) samples. Results in Results are typically available within 35 working days from sample receipt.. Free home collection in 300+ cities across India.

Liquid Biopsy Genetic PanelAdults🏠 Home Collection

🩺 Medically Reviewed By

Overview

The primary purpose of this test is to detect specific genetic mutations and PD-L1 protein levels in lung cancer patients to guide personalized therapy decisions, improve treatment efficacy, and monitor disease progression through a non-invasive liquid biopsy approach.

Test Code
31
Price
₹140,400
Sample Type
Whole blood (Liquid Biopsy)
Result Time
Results are typically available within 35 working days from sample receipt.
Fasting Required
No
Method
Next Generation Sequencing, DNA Extraction, Cell Staining
Step 1

Sample Collection

Ensure the patient has completed the OncoPro Liquid Biopsy Clinical Information Form (Form 32). No fasting is required.

Method: Venipuncture with specialized tubes

Step 2

Laboratory Analysis

Collect 20 mL whole blood in 2 Streck tubes and 8 mL in 1 EDTA tube; add preservative to EDTA tube as per kit instructions.

Step 3

Report Delivery

Ship samples immediately at 18-22°C without refrigeration or freezing. Store at room temperature for up to 72 hours.

Timeline: Results are typically available within 35 working days from sample receipt.

Patient Instructions

1
Before the Test:Complete the OncoPro Liquid Biopsy Clinical Information Form (Form 32) and ensure no specific preparation is needed beyond standard blood draw.
2
During the Test:Blood sample collection using specialized tubes at a clinic or via home collection service.
3
After the Test:Samples are shipped to the lab; results are delivered online within 35 working days.

About This Test

Who Should Get This Test

The primary purpose of this test is to detect specific genetic mutations and PD-L1 protein levels in lung cancer patients to guide personalized therapy decisions, improve treatment efficacy, and monitor disease progression through a non-invasive liquid biopsy approach.

How to Prepare

  • Use provided Streck tubes and EDTA tube from the collection kit
  • Draw 20 mL whole blood into Streck tubes and 8 mL into EDTA tube
  • Add preservative to EDTA tube using supplied syringe and needle
  • Label tubes with patient information and seal properly
  • Ship at 18-22°C; do not refrigerate or freeze

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"This test is crucial for identifying actionable mutations in lung cancer patients, enabling targeted therapies and improving outcomes based on NCCN guidelines."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeWhole blood (Liquid Biopsy)
Sample Volume20 mL whole blood in 2 Streck tubes and 8 mL whole blood in 1 Lavender Top (EDTA) tube
ContainerStreck tubes and EDTA tube with preservative
Collection MethodVenipuncture with specialized tubes

Sample Stability

Room Temperature
Refrigerator
Frozen
Sample Rejection Criteria:
  • Sample collected in wrong tubes
  • Missing or incomplete clinical information form
  • Sample hemolyzed or clotted
  • Shipping delay beyond stability window

Understanding Your Results

Results indicate the presence or absence of specific genetic mutations and PD-L1 levels, which help in selecting targeted therapies or immunotherapies for lung cancer treatment.
📊

Mutation Detected

Presence of actionable genetic alteration; consider targeted therapy as per NCCN guidelines.

📊

No Mutation Detected

Absence of tested mutations; evaluate other treatment options like chemotherapy or immunotherapy based on PD-L1 status.

📊

PD-L1 High Expression

TPS ≥ 50%; immunotherapy may be a primary option.

📊

PD-L1 Low Expression

TPS 1-49%; immunotherapy could be considered in combination with other treatments.

📊

PD-L1 Negative

TPS < 1%; immunotherapy may have limited efficacy; focus on other modalities.

⚠️ When to Consult a Doctor:

Consult an oncologist immediately if test results show mutations or if symptoms persist or worsen, for tailored treatment planning and follow-up.

Limitations

  • Detects only specific mutations included in the panel
  • Not a standalone diagnostic; requires clinical correlation
  • Sensitivity depends on tumor cell shedding into blood
  • Not recommended for early-stage cancers with low circulating tumor DNA

Risks & Considerations

  • Minimal risks associated with blood draw, such as bruising or infection at the puncture site
  • No significant procedural risks due to non-invasive nature

Interfering Factors

  • Improper sample collection or handling
  • Contamination during blood draw
  • Delay in shipping beyond 72 hours at room temperature
  • Use of incorrect tubes or preservatives

Compare With Similar Tests

TestOncoPro NCCN Lung Cancer Panel with PD-L1 TestEGFR Mutation TestPD-L1 ImmunohistochemistryComprehensive Genomic ProfilingOther Liquid Biopsy Panels
ComparisonOncoPro NCCN Lung Cancer Panel with PD-L1 Test

Frequently Asked Questions

What is the OncoPro NCCN Lung Cancer Panel with PD-L1 Test?
It is a liquid biopsy test that analyzes blood samples for genetic mutations and PD-L1 levels in lung cancer patients, based on NCCN guidelines, to guide personalized therapy.
Who should consider taking this test?
Patients diagnosed with lung cancer, especially those with symptoms like persistent cough or hemoptysis, or those seeking targeted therapy options.
How is the test sample collected?
Through a blood draw using specialized Streck and EDTA tubes, with preservative added, and shipped at controlled temperature.
What genetic mutations does this test detect?
It detects mutations in EGFR, ALK, ERBB2, BRAF, MET, RET, ROS1, NTRK1, KRAS, MSI status, and PD-L1 expression.
How long does it take to receive results?
Results are typically available within 35 working days from the date of sample receipt.
What is the cost of the test in India?
The test costs INR 140,400, with free home sample collection available for online bookings across many cities.
Is home sample collection available?
Yes, free home collection is offered for online bookings in numerous Indian cities, including Mumbai, Delhi, Bangalore, and more.
Are there any preparation requirements before the test?
No fasting is required, but the OncoPro Liquid Biopsy Clinical Information Form (Form 32) must be duly filled.
How accurate is the OncoPro test?
The test uses advanced Next Generation Sequencing for high accuracy, but results should be interpreted clinically by a healthcare provider.
What do the test results mean for treatment?
Positive mutations may indicate eligibility for targeted therapies, while PD-L1 levels can guide immunotherapy decisions as per NCCN guidelines.
Is the test covered by insurance or government schemes?
Coverage varies; it is not automatically covered under schemes like PMJAY or CGHS, so check with your provider or insurer.
Where can I get this test done in India?
The test is available through DNA Labs India with services in major cities; contact them for details or book online for home collection.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.